top of page
Abstract Line Pattern

Leukemia (CLL - Chronic Lymphocytic Leukemia)• Lymphoma (SLL - Small Lymphocytic Lymphoma)

Leukemia (CLL - Chronic Lymphocytic Leukemia)• Lymphoma (SLL - Small Lymphocytic Lymphoma)

(GLORA) A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Principal Investigator (PI)

Clinical Trials.gov ID

Key Eligibility

Protocol #

SPONSOR

Ascentage Pharma Group Corp.
bottom of page